News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Study Examines Nationwide Trends in Aortic Aneurysm Admissions and Repairs. January 31, 2025—In a multicenter, retrospective review of patients admitted with intact and ruptured abdominal aortic aneurysms (AAAs), thoracic aortic aneurysms (TAAs), and thoracoabdominal aortic aneurysms (TAAAs), Conroy et al found that use of endovascular and complex endovascular techniques increased over the ...

June 5, 2024—Baylis Medical Technologies announced the completion of its first clinical use of the PowerWire Pro radiofrequency (RF) guidewire to cross a chronically occluded peripheral stent safely.

Deep Venous Disease Patient Advocacy. Moderator Suresh Vedantham, MD, asks Leslie Lake, Volunteer President of the National Blood Clot Alliance and bilateral PE survivor, about patient and physician engagement in the organization, educational and outreach initiatives in deep vein thrombosis/pulmonary embolism, how physicians can get involved in patient advocacy, and more.

December 9, 2024—In a multicenter, prospective, nonrandomized study evaluating outcomes of fenestrated-branched endovascular aortic repair (FB-EVAR) in patients with asymptomatic, intact thoracoabdominal aortic aneurysms (TAAAs), Oderich et al found that the procedure was effective out to 5 years, with a low incidence of early and late …

June 23, 2023—Biolitec AG, headquartered in Vienna, Austria, is introducing two new products in its Elves Radial family of endolaser vein system devices for minimally invasive laser treatment of insufficient veins at the 23rd European Venous Forum held in …

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.

With many questions about the management of patients undergoing transcarotid artery revascularization (TCAR) left unanswered, a multispecialty panel of carotid experts gathered to provide guidance on the optimal medical regimen for surgeons who perform TCAR procedures. Recognizing that other ...

Teleflex: Manta Vascular Closure Device Bioresorbable implant: Following the use of 10–20 F device or sheaths (12–25 F OD) 0.035: Indicated for closure of femoral artery access sites while reducing time to hemostasis following the use of 10–20-F devices or sheaths (12–25-F OD) in endovascular catheterization procedures

November 4, 2024—The first clinical use of the Javelin peripheral intravascular lithotripsy (IVL) catheter (Shockwave Medical) for the treatment of peripheral artery disease (PAD) was evaluated in pooled data from the premarket, prospective, single-arm Mini S feasibility study and the FORWARD PAD investigational device exemption (IDE) study. The Javelin device features a forward-shifted IVL ...